{"id":"W3082666946","doi":"10.2217/fon-2020-0521","title":"Belantamab Mafodotin in the Treatment of Relapsed or Refractory Multiple Myeloma","year":2020,"lang":"en","type":"review","venue":"Future Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Janssen Biotech; Celgene; Genentech; Amgen","keywords":"Medicine; Multiple myeloma; Refractory (planetary science); Clinical trial; Oncology; Internal medicine; Antigen; Population; Chimeric antigen receptor; Antibody; Antibody-drug conjugate; Drug; Immunology; Immunotherapy; Cancer research; Cancer; Pharmacology; Monoclonal antibody","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003292299,0.0004490508,0.0009128285,0.001453387,0.0001618333,0.0005155646,0.0004537963,0.0004883799,0.003472583],"category_scores_gemma":[0.0003245469,0.0001654736,0.0004756772,0.00119702,0.0001735182,0.0005921729,0.0004001331,0.001082014,0.001450105],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003736627,"about_ca_system_score_gemma":0.0005663721,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007624606,"about_ca_topic_score_gemma":0.001698849,"domain_scores_codex":[0.999899,0.00001959002,0.00001504716,0.00001606438,0.00003929141,0.00001093076],"domain_scores_gemma":[0.9999008,0.00004323317,0.00001978936,0.000002187371,0.00002396111,0.00001003304],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001483723,0.00006795173,0.00009694607,0.0196298,0.0001241081,0.0001602965,0.00005050621,0.0003610699,0.002479974,0.001607114,0.01721995,0.958054],"study_design_scores_gemma":[0.00005174654,0.000222625,0.0007905005,0.004418298,0.0002740474,0.001287672,0.00003802684,0.0001396327,0.0007309039,0.001081354,0.9909499,0.00001522896],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002633201,0.9985387,0.00008012601,0.0001318959,0.00007533347,0.000005846804,0.00002014835,0.000007342892,0.0008772968],"genre_scores_gemma":[0.001068944,0.9981095,0.0001239609,0.0001249781,0.00005460442,0.00000646933,0.00003498975,0.000001361932,0.0004752934],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.003472583,"threshold_uncertainty_score":0.011617,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08867892424622806,"score_gpt":0.4105295756180951,"score_spread":0.3218506513718671,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}